Vaxcyte, Inc. (PCVX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2018: $1.77M2019: $1.20M2020: $1.16M2021: $6.55M2022: $5.84M2023: $16.06M2024: $22.43M2025: $13.71M$13.71M
2018Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$13.71M-38.9%
2024$22.43M+39.6%
2023$16.06M+175.0%
2022$5.84M-10.9%
2021$6.55M+467.5%
2020$1.16M-3.3%
2019$1.20M-32.6%
2018$1.77M